開開實業(600272.SH):子公司雷允上擬簽訂房屋徵收補償協議 涉及補償款1358萬元
格隆匯12月10日丨開開實業(600272.SH)公佈,按照“上海市靜安區人民政府房屋徵收決定”【滬靜府房徵(2021)7號】要求,公司全資子公司上海雷允上藥業西區有限公司(“雷允上”)位於康定路802號-806號合計建築面積111.35平方米產權非居住房屋納入“靜安區膠州路、康定路零星舊城區改建項目房屋徵收範圍”,該房屋部分由雷允上自用作為下屬子公司上海源源化學試劑有限公司的辦公場所以及部分出租。
經與上海市靜安第二房屋徵收服務事務所有限公司多次協商,雷允上擬與房屋徵收單位、房屋徵收實施單位簽訂《上海市國有土地上房屋徵收補償協議》。
根據補償協議,雷允上可獲得上述房屋的徵收補償款合計約為人民幣1358.0027萬元。徵收補償款的支付日期為協議生效後,雷允上搬離原址90日內。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.